Genetic variants in pre-eclampsia: a meta-analysis

Aggarwal, 2010, Endothelial nitric oxide synthase, angiotensin-converting enzyme and angiotensinogen gene polymorphisms in hypertensive disorders of pregnancy, Hypertens Res, 33, 473, 10.1038/hr.2010.23

Aggarwal, 2011, Preeclampsia in North Indian women: the contribution of genetic polymorphisms, J Obstet Gynaecol Res, 37, 1335, 10.1111/j.1447-0756.2010.01523.x

Agorastos, 2002, Factor V Leiden and prothrombin G20210A mutations in pregnancies with adverse outcome, J Matern Fetal Neonatal Med, 12, 267, 10.1080/jmf.12.4.267.273

Akbar, 2009, Angiotensin II type 1 and 2 receptors gene polymorphisms in pre-eclampsia and normal pregnancy in three different populations, Acta Obstet Gynecol Scand, 88, 606, 10.1080/00016340902859307

Alfirevic, 2001, Postnatal screening for thrombophilia in women with severe pregnancy complications, Obstet Gynecol, 97, 753

Al-Habboubi, 2011, Contribution of VEGF polymorphisms to variation in VEGF serum levels in a healthy population, Eur Cytokine Netw, 22, 154, 10.1684/ecn.2011.0289

Also-Rallo, 2005, Polymorphisms of genes involved in homocysteine metabolism in preeclampsia and in uncomplicated pregnancies, Eur J Obstet Gynecol Reprod Biol, 120, 45, 10.1016/j.ejogrb.2004.08.008

Arngrimsson, 1990, Genetic and familial predisposition to eclampsia and pre-eclampsia in a defined population, Br J Obstet Gynaecol, 97, 762, 10.1111/j.1471-0528.1990.tb02569.x

Balam-Ortiz, 2011, Variants and haplotypes in angiotensinogen gene are associated with plasmatic angiotensinogen level in Mexican population, Am J Med Sci, 342, 205, 10.1097/MAJ.0b013e3182121020

Bashford, 2001, Angiotensinogen and endothelial nitric oxide synthase gene polymorphisms among Hispanic patients with preeclampsia, Am J Obstet Gynecol, 184, 1345, 10.1067/mob.2001.115048

Bellamy, 2007, Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis, Br Med J, 335, 974, 10.1136/bmj.39335.385301.BE

Belo, 2004, Apolipoprotein E and cholesteryl ester transfer protein polymorphisms in normal and preeclamptic pregnancies, Eur J Obstet Gynecol Reprod Biol, 112, 9, 10.1016/S0301-2115(03)00240-9

Benedetto, 2002, Factor V Leiden and factor II G20210A in preeclampsia and HELLP syndrome, Acta Obstet Gynecol Scand, 81, 1095, 10.1034/j.1600-0412.2002.811201.x

Benedetto, 2007, Synergistic effect of renin–angiotensin system and nitric oxide synthase genes polymorphisms in pre-eclampsia, Acta Obstet Gynecol Scand, 86, 678, 10.1080/00016340701415269

Bernard, 2007, The combination of ApoCIII, hepatic lipase and hormono sensitive lipase gene polymorphisms suggests an association with susceptibility to gestational hypertension, J Hum Genet, 52, 244, 10.1007/s10038-006-0106-1

Bertina, 1994, Mutation in blood coagulation factor V associated with resistance to activated protein C, Nature, 369, 64, 10.1038/369064a0

Best, 2009, Genetic thrombophilia variants and risk for preeclampsia among American Indians, Hypertens Pregnancy, 28, 85, 10.1080/10641950802419887

Best, 2010, Genetic variants, endothelial function, and risk of preeclampsia among American Indians, Hypertens Pregnancy

Best, 2012, Genetic variants, immune function, and risk of pre-eclampsia among American Indians, Am J Reprod Immunol, 67, 152, 10.1111/j.1600-0897.2011.01076.x

Bombell, 2008, Tumour necrosis factor (-308A) polymorphism in pre-eclampsia: meta-analysis of 16 case-control studies, Aust N Z J Obstet Gynaecol, 48, 547, 10.1111/j.1479-828X.2008.00924.x

Bouba, 2003, Interaction between the polymorphisms of the renin–angiotensin system in preeclampsia, Eur J Obstet Gynecol Reprod Biol, 110, 8, 10.1016/S0301-2115(03)00046-0

Brown, 2001, The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP), Hypertens Pregnancy, 20, IX, 10.3109/10641950109152635

Canto, 2008, Methylenetetrahydrofolate reductase C677T and glutathione S-transferase P1 A313G are associated with a reduced risk of preeclampsia in Maya–Mestizo women, Hypertens Res, 31, 1015, 10.1291/hypres.31.1015

Canto-Cetina, 2007, Analysis of C-850T and G-308A polymorphisms of the tumor necrosis factor-alpha gene in Maya–Mestizo women with preeclampsia, Hypertens Pregnancy, 26, 283, 10.1080/10641950701372732

Ceelie, 2004, G20210A is a functional mutation in the prothrombin gene; effect on protein levels and 3′-end formation, J Thromb Haemost, 2, 119, 10.1111/j.1538-7836.2003.00493.x

Chappell, 2006, Searching for genetic clues to the causes of pre-eclampsia, Clin Sci (Lond), 110, 443, 10.1042/CS20050323

Chen, 1996, Tumour necrosis factor-alpha (TNF-alpha) gene polymorphism and expression in pre-eclampsia, Clin Exp Immunol, 104, 154, 10.1046/j.1365-2249.1996.d01-647.x

Chen, 2007, Polymorphisms in the endothelial nitric oxide synthase gene may be protective against preeclampsia in a Chinese population, Reprod Sci, 14, 175, 10.1177/1933719107299570

Chesley, 1986, Genetics of hypertension in pregnancy: possible single gene control of pre-eclampsia and eclampsia in the descendants of eclamptic women, Br J Obstet Gynaecol, 93, 898, 10.1111/j.1471-0528.1986.tb08006.x

Chikosi, 1999, 5,10-Methylenetetrahydrofolate reductase polymorphism in black South African women with pre-eclampsia, Br J Obstet Gynaecol, 106, 1219, 10.1111/j.1471-0528.1999.tb08152.x

Chikosi, 2000, Apolipoprotein E polymorphism in South African Zulu women with preeclampsia, Hypertens Pregnancy, 19, 309, 10.1081/PRG-100101992

Choi, 2004, Association of angiotensin-converting enzyme and angiotensinogen gene polymorphisms with preeclampsia, J Korean Med Sci, 19, 253, 10.3346/jkms.2004.19.2.253

Cincotta, 1998, Family history of pre-eclampsia as a predictor for pre-eclampsia in primigravidas, Int J Gynaecol Obstet, 60, 23, 10.1016/S0020-7292(97)00241-5

Currie, 2002, Is there an increased maternal-infant prevalence of Factor V Leiden in association with severe pre-eclampsia?, BJOG, 109, 191

Daher, 2006, Cytokine genotyping in preeclampsia, Am J Reprod Immunol, 55, 130, 10.1111/j.1600-0897.2005.00341.x

Dalmaz, 2006, Relationship between polymorphisms in thrombophilic genes and preeclampsia in a Brazilian population, Blood Cells Mol Dis, 37, 107, 10.1016/j.bcmd.2006.07.005

Davalos, 2005, Methylenetetrahydrofolate reductase C677T polymorphism and Factor V Leiden variant in Mexican women with preeclampsia/eclampsia, Blood Cells Mol Dis, 35, 66, 10.1016/j.bcmd.2005.03.008

de Groot, 1999, Preeclampsia and genetic risk factors for thrombosis: a case–control study, Am J Obstet Gynecol, 181, 975, 10.1016/S0002-9378(99)70335-2

de Groot, 2004, Interleukin 10-2849AA genotype protects against pre-eclampsia, Genes Immun, 5, 313, 10.1038/sj.gene.6364092

de Lima, 2009, Cytokine gene polymorphisms in preeclampsia and eclampsia, Hypertens Res, 32, 565, 10.1038/hr.2009.58

De Maat, 2004, Preeclampsia and its interaction with common variants in thrombophilia genes, J Thromb Haemost, 2, 1588, 10.1111/j.1538-7836.2004.00861.x

Demir, 2006, The relationship between pregnancy induced hypertension and congenital thrombophilia, Saudi Med J, 27, 1161

Diaz-Olguin, 2011, Endothelial nitric oxide synthase haplotypes are associated with preeclampsia in Maya mestizo women, Dis Markers, 31, 83, 10.1155/2011/380153

Dissanayake, 2009, A study of three candidate genes for pre-eclampsia in a Sinhalese population from Sri Lanka, J Obstet Gynaecol Res, 35, 234, 10.1111/j.1447-0756.2008.00926.x

Dizon-Townson, 1996, The factor V Leiden mutation may predispose women to severe preeclampsia, Am J Obstet Gynecol, 175, 902, 10.1016/S0002-9378(96)80022-6

Dizon-Townson, 1998, A promoter mutation in the tumor necrosis factor alpha gene is not associated with preeclampsia, J Reprod Immunol, 38, 55, 10.1016/S0165-0378(98)00008-4

Dogan, 2011, Frequency of hereditary thrombophilia, anticoagulant activity, and homocysteine levels in patients with hemolysis, elevated liver functions and low thrombocyte count (HELLP) syndrome, J Obstet Gynaecol Res, 37, 527, 10.1111/j.1447-0756.2010.01397.x

Dudding, 2008, Factor V Leiden is associated with pre-eclampsia but not with fetal growth restriction: a genetic association study and meta-analysis, J Thromb Haemost, 6, 1869, 10.1111/j.1538-7836.2008.03134.x

Dusse, 2007, Inherited thrombophilias and pre-eclampsia in Brazilian women, Eur J Obstet Gynecol Reprod Biol, 134, 20, 10.1016/j.ejogrb.2006.09.006

Esplin, 2001, Paternal and maternal components of the predisposition to preeclampsia, N Engl J Med, 344, 867, 10.1056/NEJM200103223441201

Fabbro, 2003, Association between plasminogen activator inhibitor 1 gene polymorphisms and preeclampsia, Gynecol Obstet Invest, 56, 17, 10.1159/000072326

Faisel, 2004, Susceptibility to pre-eclampsia in Finnish women is associated with R485K polymorphism in the factor V gene, not with Leiden mutation, Eur J Hum Genet, 12, 187, 10.1038/sj.ejhg.5201124

Fatini, 2006, Endothelial nitric oxide synthase gene influences the risk of pre-eclampsia, the recurrence of negative pregnancy events, and the maternal-fetal flow, J Hypertens, 24, 1823, 10.1097/01.hjh.0000242407.58159.87

Fisher, 1997, Common variation in the lipoprotein lipase gene: effects on plasma lipids and risk of atherosclerosis, Atherosclerosis, 135, 145, 10.1016/S0021-9150(97)00199-8

Franchim, 2011, Inflammatory mediators gene polymorphisms in preeclampsia, Hypertens Pregnancy, 30, 338, 10.3109/10641950903455389

Francoual, 2002, Is a polymorphism of the apolipoprotein E gene associated with preeclampsia?, Hypertens Pregnancy, 21, 127, 10.1081/PRG-120004768

Freeman, 2004, Short- and long-term changes in plasma inflammatory markers associated with preeclampsia, Hypertension, 44, 708, 10.1161/01.HYP.0000143849.67254.ca

Frosst, 1995, A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase, Nat Genet, 10, 111, 10.1038/ng0595-111

Galao, 2004, Angiotensin-converting enzyme gene polymorphism in preeclampsia and normal pregnancy, Am J Obstet Gynecol, 191, 821, 10.1016/j.ajog.2004.01.047

Gerhardt, 2005, The G20210A prothrombin-gene mutation and the plasminogen activator inhibitor (PAI-1) 5G/5G genotype are associated with early onset of severe preeclampsia, J Thromb Haemost, 3, 686, 10.1111/j.1538-7836.2005.01226.x

Grandone, 1999, Prothrombotic genetic risk factors and the occurrence of gestational hypertension with or without proteinuria, Thromb Haemost, 81, 349, 10.1055/s-0037-1614475

Grandone, 2003, Does endothelial nitric oxide synthase gene variation play a role in the occurrence of hypertension in pregnancy?, Hypertens Pregnancy, 22, 149, 10.1081/PRG-120021061

Guo, 1997, Angiotensinogen gene variation in a population case–control study of preeclampsia/eclampsia in Australians and Chinese, Electrophoresis, 18, 1646, 10.1002/elps.1150180929

Gurdol, 2004, The association between preeclampsia and angiotensin-converting enzyme insertion/deletion polymorphism, Clin Chim Acta, 341, 127, 10.1016/j.cccn.2003.11.010

Haggerty, 2005, Association between allelic variants in cytokine genes and preeclampsia, Am J Obstet Gynecol, 193, 209, 10.1016/j.ajog.2004.11.008

Hakli, 2003, Endothelial nitric oxide synthase polymorphism in preeclampsia, J Soc Gynecol Investig, 10, 154, 10.1016/S1071-5576(03)00003-0

Hannaford, 1997, Cardiovascular sequelae of toxaemia of pregnancy, Heart, 77, 154, 10.1136/hrt.77.2.154

Healy, 2006, UCHL-1 is not a Parkinson's disease susceptibility gene, Ann Neurol, 59, 627, 10.1002/ana.20757

Heiskanen, 2001, Insertion-deletion polymorphism in the gene for angiotensin-converting enzyme is associated with obstetric cholestasis but not with preeclampsia, Am J Obstet Gynecol, 185, 600, 10.1067/mob.2001.116722

Heiskanen, 2002, Polymorphism in the tumor necrosis factor-alpha gene in women with preeclampsia, J Assist Reprod Genet, 19, 220, 10.1023/A:1015306818507

Higgins, 2000, Prothrombin G20210A mutation: is it associated with pre-eclampsia?, Gynecol Obstet Invest, 50, 254, 10.1159/000010326

Higgins, 2003, Measuring inconsistency in meta-analyses, Br Med J, 327, 557, 10.1136/bmj.327.7414.557

Hill, 2011, Epistasis between COMT and MTHFR in maternal-fetal dyads increases risk for preeclampsia, PLoS One, 6, e16681, 10.1371/journal.pone.0016681

Hiltunen, 2009, Blood group AB and factor V Leiden as risk factors for pre-eclampsia: a population-based nested case-control study, Thromb Res, 124, 167, 10.1016/j.thromres.2008.11.012

Hubel, 1999, Association of pre-eclampsia with common coding sequence variations in the lipoprotein lipase gene, Clin Genet, 56, 289, 10.1034/j.1399-0004.1999.560406.x

Ioannidis, 2005, Early extreme contradictory estimates may appear in published research: the Proteus phenomenon in molecular genetics research and randomized trials, J Clin Epidemiol, 58, 543, 10.1016/j.jclinepi.2004.10.019

Ioannidis, 2001, Replication validity of genetic association studies, Nat Genet, 29, 306, 10.1038/ng749

Irgens, 2001, Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study, Br Med J, 323, 1213, 10.1136/bmj.323.7323.1213

Isermann, 2003, The thrombomodulin-protein C system is essential for the maintenance of pregnancy, Nat Med, 9, 331, 10.1038/nm825

Jaaskelainen, 2006, MTHFR C677T polymorphism is not associated with placental abruption or preeclampsia in Finnish women, Hypertens Pregnancy, 25, 73, 10.1080/10641950600745137

Jaaskelainen, 2008, CTLA-4 polymorphism 49A-G is associated with placental abruption and preeclampsia in Finnish women, Clin Chem Lab Med, 46, 169, 10.1515/CCLM.2008.034

Jarvenpaa, 2006, Evaluation of factor V Leiden, prothrombin and methylenetetrahydrofolate reductase gene mutations in patients with severe pregnancy complications in northern Finland, Gynecol Obstet Invest, 62, 28, 10.1159/000091814

Jenkins, 2008, Preeclampsia risk and angiotensinogen polymorphisms M235T and AGT -217 in African American and Caucasian women, Reprod Sci, 15, 696, 10.1177/1933719108316984

Jeunemaitre, 1992, Molecular basis of human hypertension: role of angiotensinogen, Cell, 71, 169, 10.1016/0092-8674(92)90275-H

Jonsdottir, 1995, Death rates from ischemic heart disease in women with a history of hypertension in pregnancy, Acta Obstet Gynecol Scand, 74, 772, 10.3109/00016349509021195

Kaiser, 2001, C677T methylenetetrahydrofolate reductase polymorphism is not a risk factor for pre-eclampsia/eclampsia among Australian women, Hum Hered, 51, 20, 10.1159/000022954

Kaiser, 2004, Association of the TNF2 allele with eclampsia, Gynecol Obstet Invest, 57, 204, 10.1159/000076689

Kamali-Sarvestani, 2006, Association study of IL-10 and IFN-gamma gene polymorphisms in Iranian women with preeclampsia, J Reprod Immunol, 72, 118, 10.1016/j.jri.2006.04.001

Kankova, 2000, Lack of association between pregnancy-induced hypertension and familial thrombophilia in a Czech population, Prenat Neonatal Med, 5, 223

Karakantza, 2008, Inheritance and perinatal consequences of inherited thrombophilia in Greece, Int J Gynecol Obstet, 100, 124, 10.1016/j.ijgo.2007.08.006

Karimi, 2012, Evaluation the frequency of factor V Leiden mutation in pregnant women with preeclampsia syndrome in an Iranian population, Iran J Reprod Med, 10, 59

Kaur, 2005, Association of angiotensin-converting enzyme gene polymorphism with pregnancy-induced hypertension, Acta Obstet Gynecol Scand, 84, 929, 10.1111/j.0001-6349.2005.00724.x

Keavney, 2000, Large-scale test of hypothesised associations between the angiotensin-converting-enzyme insertion/deletion polymorphism and myocardial infarction in about 5000 cases and 6000 controls. International Studies of Infarct Survival (ISIS) Collaborators, Lancet, 355, 434, 10.1016/S0140-6736(00)82009-7

Kiechl, 2002, Toll-like receptor 4 polymorphisms and atherogenesis, N Engl J Med, 347, 185, 10.1056/NEJMoa012673

Kim, 2001, Lipoprotein lipase gene mutations and the genetic susceptibility of preeclampsia, Hypertension, 38, 992, 10.1161/hy1101.093105

Kim, 2001, Genetic susceptibility to preeclampsia: roles of cytosineto-thymine substitution at nucleotide 677 of the gene for methylenetetrahydrofolate reductase, 68-base pair insertion at nucleotide 844 of the gene for cystathionine beta-synthase, and factor V Leiden mutation, Am J Obstet Gynecol, 184, 1211, 10.1067/mob.2001.110411

Kim, 2006, Reduced L-arginine level and decreased placental eNOS activity in preeclampsia, Placenta, 27, 438, 10.1016/j.placenta.2005.04.011

Kim, 2008, No association of the genetic polymorphisms of endothelial nitric oxide synthase, dimethylarginine dimethylaminohydrolase, and vascular endothelial growth factor with preeclampsia in Korean populations, Twin Res Hum Genet, 11, 77, 10.1375/twin.11.1.77

Klai, 2011, Association of MTHFR A1298C polymorphism (but not of MTHFR C677T) with elevated homocysteine levels and placental vasculopathies, Blood Coagul Fibrinolysis, 22, 374, 10.1097/MBC.0b013e328344f80f

Knyrim, 2008, Genetic analysis of the angiotensinogen gene in pre-eclampsia: study of german women and review of the literature, Gynecol Obstet Invest, 66, 203, 10.1159/000146084

Kobashi, 1999, Association of a variant of the angiotensinogen gene with pure type of hypertension in pregnancy in the Japanese: implication of a racial difference and significance of an age factor, Am J Med Genet, 86, 232, 10.1002/(SICI)1096-8628(19990917)86:3<232::AID-AJMG7>3.0.CO;2-2

Kobashi, 2000, Absence of association between a common mutation in the methylenetetrahydrofolate reductase gene and preeclampsia in Japanese women, Am J Med Genet, 93, 122, 10.1002/1096-8628(20000717)93:2<122::AID-AJMG8>3.0.CO;2-Z

Kobashi, 2001, Endothelial nitric oxide synthase gene (NOS3) variant and hypertension in pregnancy, Am J Med Genet, 103, 241, 10.1002/ajmg.1535

Kobashi, 2005, Insertion/deletion polymorphism of the angiotensin-converting enzyme gene and preeclampsia in Japanese patients, Semin Thromb Hemost, 31, 346, 10.1055/s-2005-872442

Kroeger, 1997, The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription, Mol Immunol, 34, 391, 10.1016/S0161-5890(97)00052-7

Kupferminc, 1999, Increased frequency of genetic thrombophilia in women with complications of pregnancy, N Engl J Med, 340, 9, 10.1056/NEJM199901073400102

Kupferminc, 2000, Severe preeclampsia and high frequency of genetic thrombophilic mutations, Obstet Gynecol, 96, 45

Kupferminc, 2000, High prevalence of the prothrombin gene mutation in women with intrauterine growth retardation, abruptio placentae and second trimester loss, Acta Obstet Gynecol Scand, 79, 963, 10.1034/j.1600-0412.2000.079011963.x

Kyrle, 1998, Clinical studies and thrombin generation in patients homozygous or heterozygous for the G20210A mutation in the prothrombin gene, Arterioscler Thromb Vasc Biol, 18, 1287, 10.1161/01.ATV.18.8.1287

Laivuori, 2000, 677 C–>T polymorphism of the methylenetetrahydrofolate reductase gene and preeclampsia, Obstet Gynecol, 96, 277

Landau, 2004, No association of the Asp298 variant of the endothelial nitric oxide synthase gene with preeclampsia, Am J Hypertens, 17, 391, 10.1016/j.amjhyper.2004.01.006

Larciprete, 2007, Single inherited thrombophilias and adverse pregnancy outcomes, J Obstet Gynaecol Res, 33, 423, 10.1111/j.1447-0756.2007.00550.x

Le, 2000, Association of the R485K polymorphism of the factor V gene with poor response to activated protein C and increased risk of coronary artery disease in the Chinese population, Clin Genet, 57, 296, 10.1034/j.1399-0004.2000.570409.x

Levesque, 2004, Implication of an AGT haplotype in a multigene association study with pregnancy hypertension, Hypertension, 43, 71, 10.1161/01.HYP.0000104525.76016.77

Li, 2007, Angiotensin-converting enzyme insertion/deletion (ACE I/D) and angiotensin II type 1 receptor (AT1R) gene polymorphism and its association with preeclampsia in Chinese women, Hypertens Pregnancy, 26, 293, 10.1080/10641950701413676

Lin, 2005, Genetic thrombophilias and preeclampsia: a meta-analysis, Obstet Gynecol, 105, 182, 10.1097/01.AOG.0000146250.85561.e9

Lin, 2009, The plasminogen activator inhibitor-1 (PAI-1) gene -844 A/G and -675 4G/5G promoter polymorphism significantly influences plasma PAI-1 levels in women with polycystic ovary syndrome, Endocrine, 36, 503, 10.1007/s12020-009-9255-2

Lindoff, 1997, Preeclampsia is associated with a reduced response to activated protein C, Am J Obstet Gynecol, 176, 457, 10.1016/S0002-9378(97)70515-5

Livingston, 2001, Maternal and fetal inherited thrombophilias are not related to the development of severe preeclampsia, Am J Obstet Gynecol, 185, 153, 10.1067/mob.2001.114691

Malek-Khosravi, 2011, Thrombophilic mutations and susceptibility to preeclapmsia in Western Iran, J Thromb Thrombolysis

Mando, 2009, Angiotensin-converting enzyme and adducin-1 polymorphisms in women with preeclampsia and gestational hypertension, Reprod Sci, 16, 819, 10.1177/1933719109336612

Mayret-Mesquiti, 2007, Hypertriglyceridemia is linked to reduced nitric oxide synthesis in women with hypertensive disorders of pregnancy, Hypertens Pregnancy, 26, 423, 10.1080/10641950701521569

McCarthy, 2008, Genome-wide association studies for complex traits: consensus, uncertainty and challenges, Nat Rev Genet, 9, 356, 10.1038/nrg2344

Medica, 2007, Genetic polymorphisms in vasoactive genes and preeclampsia: a meta-analysis, Eur J Obstet Gynecol Reprod Biol, 131, 115, 10.1016/j.ejogrb.2006.10.005

Mello, 1999, Usefulness of screening for congenital or acquired hemostatic abnormalities in women with previous complicated pregnancies, Haemostasis, 29, 197

Mello, 2005, Thrombophilia is significantly associated with severe preeclampsia: results of a large-scale, case-controlled study, Hypertension, 46, 1270, 10.1161/01.HYP.0000188979.74172.4d

Mendilcioglu, 2011, The association between inherited thrombophilias and pregnancy-related hypertension recurrence, Arch Gynecol Obstet, 284, 837, 10.1007/s00404-010-1756-y

Mirahmadian, 2008, Association of tumor necrosis factor-alpha and interleukin-10 gene polymorphisms in Iranian patients with pre-eclampsia, Am J Reprod Immunol, 60, 179, 10.1111/j.1600-0897.2008.00610.x

Miskovic, 2008, Association of angiotensin-converting enzyme insertion-deletion polymorphism with preeclampsia, Coll Antropol, 32, 339

Molvarec, 2008, Toll-like receptor 4 gene polymorphisms and preeclampsia: lack of association in a Caucasian population, Hypertens Res, 31, 859, 10.1291/hypres.31.859

Molvarec, 2008, Association between tumor necrosis factor (TNF)-alpha G-308A gene polymorphism and preeclampsia complicated by severe fetal growth restriction, Clin Chim Acta, 392, 52, 10.1016/j.cca.2008.03.009

Molvarec, 2008, Association between tumor necrosis factor (TNF)-alpha G-308A gene polymorphism and preeclampsia complicated by severe fetal growth restriction, Clin Chim Acta, 392, 52, 10.1016/j.cca.2008.03.009

Mooyaart, 2011, Genetic associations in diabetic nephropathy: a meta-analysis, Diabetologia, 54, 544, 10.1007/s00125-010-1996-1

Morgan, 1998, Distortion of maternal-fetal angiotensin II type 1 receptor allele transmission in pre-eclampsia, J Med Genet, 35, 632, 10.1136/jmg.35.8.632

Morgan, 1999, Maternal and fetal angiotensinogen gene allele sharing in pre-eclampsia, Br J Obstet Gynaecol, 106, 244, 10.1111/j.1471-0528.1999.tb08238.x

Morgan, 1999, Angiotensin-converting enzyme insertion-deletion polymorphism in normotensive and pre-eclamptic pregnancies, J Hypertens, 17, 765, 10.1097/00004872-199917060-00007

Morrison, 2002, Prothrombotic genotypes are not associated with pre-eclampsia and gestational hypertension: results from a large population-based study and systematic review, Thromb Haemost, 87, 779, 10.1055/s-0037-1613083

Murphy, 2000, Prospective evaluation of the risk conferred by factor V Leiden and thermolabile methylenetetrahydrofolate reductase polymorphisms in pregnancy, Arterioscler Thromb Vasc Biol, 20, 266, 10.1161/01.ATV.20.1.266

Nagy, 1998, Apolipoprotein E alleles in women with severe pre-eclampsia, J Clin Pathol, 51, 324, 10.1136/jcp.51.4.324

Nagy, 2007, High frequency of methylenetetrahydrofolate reductase 677TT genotype in Hungarian HELLP syndrome patients determined by quantitative real-time PCR, J Hum Hypertens, 21, 154, 10.1038/sj.jhh.1002122

Nakayama, 1999, T-786–>C mutation in the 5′-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm, Circulation, 99, 2864, 10.1161/01.CIR.99.22.2864

Nilsson, 2004, The importance of genetic and environmental effects for pre-eclampsia and gestational hypertension: a family study, BJOG, 111, 200, 10.1111/j.1471-0528.2004.00042x.x

Nishizawa, 2009, Analysis of nitric oxide metabolism as a placental or maternal factor underlying the etiology of pre-eclampsia, Gynecol Obstet Invest, 68, 239, 10.1159/000238381

Omar, 2008, Thrombophilic mutations in pre-eclampsia and pregnancy-induced hypertension, J Obstet Gynaecol Res, 34, 174, 10.1111/j.1447-0756.2008.00755.x

O'Shaughnessy, 1999, Factor V Leiden and thermolabile methylenetetrahydrofolate reductase gene variants in an East Anglian preeclampsia cohort, Hypertension, 33, 1338, 10.1161/01.HYP.33.6.1338

O'Shaughnessy, 2001, Thrombophilic polymorphisms in pre-eclampsia: altered frequency of the functional 98C>T polymorphism of glycoprotein IIIa, J Med Genet, 38, 775, 10.1136/jmg.38.11.775

Ozturk, 2011, Endothelial nitric oxide synthase gene polymorphisms in preeclampsia with or without eclampsia in a Turkish population, J Obstet Gynaecol Res, 10.1111/j.1447-0756.2011.01606.x

Papazoglou, 2004, Vascular endothelial growth factor gene polymorphisms and pre-eclampsia, Mol Hum Reprod, 10, 321, 10.1093/molehr/gah048

Pappa, 2011, Variable effects of maternal and paternal-fetal contribution to the risk for preeclampsia combining GSTP1, eNOS, and LPL gene polymorphisms, J Matern Fetal Neonatal Med, 24, 628, 10.3109/14767058.2010.511351

Pazarbasi, 2007, Polymorphisms in the tumor necrosis factor-alpha gene in Turkish women with pre-eclampsia and eclampsia, Acta Med Okayama, 61, 153

Pegoraro, 2003, Plasminogen activator inhibitor type 1 (PAI1) and platelet glycoprotein IIIa (PGIIIa) polymorphisms in Black South Africans with pre-eclampsia, Acta Obstet Gynecol Scand, 82, 313, 10.1034/j.1600-0412.2003.00085.x

Pegoraro, 2004, Methylenetetrahydrofolate reductase gene polymorphisms in black South Africans and the association with preeclampsia, Acta Obstet Gynecol Scand, 83, 449, 10.1111/j.0001-6349.2004.0355.x

Pendeloski, 2011, Immunoregulatory gene polymorphisms in women with preeclampsia, Hypertens Res, 34, 384, 10.1038/hr.2010.247

Perez-Mutul, 2004, A mutation in the 5,10-methylenetetrahydrofolate reductase gene is not associated with preeclampsia in women of southeast Mexico, Arch Med Res, 35, 231, 10.1016/j.arcmed.2004.02.004

Plummer, 2004, Haplotypes of the angiotensin II receptor genes AGTR1 and AGTR2 in women with normotensive pregnancy and women with preeclampsia, Hum Mutat, 24, 14, 10.1002/humu.20050

Poort, 1996, A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis, Blood, 88, 3698, 10.1182/blood.V88.10.3698.bloodjournal88103698

Powers, 1999, Methylenetetrahydrofolate reductase polymorphism, folate, and susceptibility to preeclampsia, J Soc Gynecol Investig, 6, 74, 10.1177/107155769900600205

Prasmusinto, 2002, The methylenetetrahydrofolate reductase 677 C–>T polymorphism and preeclampsia in two populations, Obstet Gynecol, 99, 1085

Prasmusinto, 2004, Ethnic differences in the association of factor V Leiden mutation and the C677T methylenetetrahydrofolate reductase gene polymorphism with preeclampsia, Eur J Obstet Gynecol Reprod Biol, 112, 162, 10.1016/S0301-2115(03)00314-2

Procopciuc, 2009, Influence of RAS polymorphisms on the development and perinatal outcome of preeclampsia. Genetic RAS evaluation, Gineco Ro, 5, 88

Procopciuc, 2010, Mutant maternal and fetal thrombophilic genotypes as a risk factor for preeclampsia, Gineco Ro, 6, 74

Procopciuc, 2011, Apolipoprotein E polymorphism—a risk factor in Romanian pregnant women with preeclampsia, Gineco Ro, 7, 134

Puthothu, 2009, Association of TNF-alpha with severe respiratory syncytial virus infection and bronchial asthma, Pediatr Allergy Immunol, 20, 157, 10.1111/j.1399-3038.2008.00751.x

Rajkovic, 2000, Methylenetetrahydrofolate reductase 677C–>T polymorphism, plasma folate, vitamin B(12) concentrations, and risk of preeclampsia among black African women from Zimbabwe, Mol Genet Metab, 69, 33, 10.1006/mgme.1999.2952

Rallidis, 2010, Reduced carriership of 4G allele of plasminogen activator inhibitor-1 4G/5G polymorphism in very young survivors of myocardial infarction, J Thromb Thrombolysis, 29, 497, 10.1007/s11239-009-0398-z

Rigo, 2000, Maternal and neonatal outcome of preeclamptic pregnancies: the potential roles of factor V Leiden mutation and 5,10 methylenetetrahydrofolate reductase, Hypertens Pregnancy, 19, 163, 10.1081/PRG-100100132

Roberts, 2004, Hypertension-related gene polymorphisms in pre-eclampsia, eclampsia and gestational hypertension in Black South African women, J Hypertens, 22, 945, 10.1097/00004872-200405000-00016

Rodie, 2004, Pre-eclampsia and cardiovascular disease: metabolic syndrome of pregnancy?, Atherosclerosis, 175, 189, 10.1016/j.atherosclerosis.2004.01.038

Ruggiero, 2011, Genetics of VEGF serum variation in human isolated populations of cilento: importance of VEGF polymorphisms, PLoS One, 6, e16982, 10.1371/journal.pone.0016982

Saarela, 2005, Tumour necrosis factor-alpha gene haplotype is associated with pre-eclampsia, Mol Hum Reprod, 11, 437, 10.1093/molehr/gah182

Sagoo, 2008, Seven lipoprotein lipase gene polymorphisms, lipid fractions, and coronary disease: a HuGE association review and meta-analysis, Am J Epidemiol, 168, 1233, 10.1093/aje/kwn235

Salimi, 2011, Association of angiotensin-converting enzyme intron 16 insertion/deletion and angiotensin II type 1 receptor A1166C gene polymorphisms with preeclampsia in South East of Iran, J Biomed Biotechnol, 2011, 941515, 10.1155/2011/941515

Salimi, 2011, Lack of relationship between endothelial nitric oxide synthase gene 4b/a and T-786C polymorphisms with preeclampsia in southeast of Iran, Arch Gynecol Obstet

Samsami, 2005, Heterozygosity in CTLA-4 gene and severe preeclampsia, Int J Gynaecol Obstet, 88, 19, 10.1016/j.ijgo.2004.09.007

Sandrim, 2008, eNOS haplotypes associated with gestational hypertension or preeclampsia, Pharmacogenomics, 9, 1467, 10.2217/14622416.9.10.1467

Sandrim, 2010, Effects of eNOS polymorphisms on nitric oxide formation in healthy pregnancy and in pre-eclampsia, Mol Hum Reprod, 16, 506, 10.1093/molehr/gaq030

Sayed-Tabatabaei, 2006, ACE polymorphisms, Circ Res, 98, 1123, 10.1161/01.RES.0000223145.74217.e7

Seremak-Mrozikiewicz, 2005, 1166C mutation of angiotensin II type 1 receptor gene is correlated with umbilical blood flow velocimetry in women with preeclampsia, J Matern Fetal Neonatal Med, 17, 117, 10.1080/jmf.17.2.117.121

Seremak-Mrozikiewicz, 2010, The significance of genetic polymorphisms of factor V Leiden and prothrombin in the preeclamptic Polish women, J Thromb Thrombolysis, 30, 97, 10.1007/s11239-009-0432-1

Seremak-Mrozikiewicz, 2011, The significance of -786T > C polymorphism of endothelial NO synthase (eNOS) gene in severe preeclampsia, J Matern Fetal Neonatal Med, 24, 432, 10.3109/14767058.2010.511329

Serrano, 2004, Endothelial NO synthase genotype and risk of preeclampsia: a multicenter case–control study, Hypertension, 44, 702, 10.1161/01.HYP.0000143483.66701.ec

Serrano, 2006, Angiotensin-converting enzyme I/D polymorphism and preeclampsia risk: evidence of small-study bias, PLoS Med, 3, e520, 10.1371/journal.pmed.0030520

Sharma, 2011, Oxidative stress and eNOS (Glu298Asp) gene polymorphism in preeclampsia in Indian population, Mol Cell Biochem, 353, 189, 10.1007/s11010-011-0786-5

Shim, 2007, Vascular endothelial growth factor gene +936 C/T polymorphism is associated with preeclampsia in Korean women, Am J Obstet Gynecol, 197, 271, 10.1016/j.ajog.2007.06.045

Singh, 2010, Role of inflammatory cytokines and eNOS gene polymorphism in pathophysiology of pre-eclampsia, Am J Reprod Immunol, 63, 244, 10.1111/j.1600-0897.2009.00781.x

Smith, 2001, Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129,290 births, Lancet, 357, 2002, 10.1016/S0140-6736(00)05112-6

Sofowora, 2001, In-vivo effects of Glu298Asp endothelial nitric oxide synthase polymorphism, Pharmacogenetics, 11, 809, 10.1097/00008571-200112000-00009

Sohda, 1997, Methylenetetrahydrofolate reductase polymorphism and pre-eclampsia, J Med Genet, 34, 525, 10.1136/jmg.34.6.525

Steegers, 2010, Pre-eclampsia, Lancet, 376, 631, 10.1016/S0140-6736(10)60279-6

Stiefel, 2009, Genotype of the CYBA promoter -930A/G, polymorphism C677T of the MTHFR and APOE genotype in patients with hypertensive disorders of pregnancy: an observational study, Med Clin (Barc), 133, 657, 10.1016/j.medcli.2009.03.042

Stonek, 2008, Absence of an association of tumor necrosis factor (TNF)-alpha G308A, interleukin-6 (IL-6) G174C and interleukin-10 (IL-10) G1082A polymorphism in women with preeclampsia, J Reprod Immunol, 77, 85, 10.1016/j.jri.2007.04.003

Stonek, 2008, Interleukin-10-1082 G/A promoter polymorphism and pregnancy complications: results of a prospective cohort study in 1,616 pregnant women, Acta Obstet Gynecol Scand, 87, 430, 10.1080/00016340801995657

Sun, 2008, Functional genetic variations in cytotoxic T-lymphocyte antigen 4 and susceptibility to multiple types of cancer, Cancer Res, 68, 7025, 10.1158/0008-5472.CAN-08-0806

Sutherland, 1981, The indicence of severe pre-eclampsia amongst mothers and mothers-in-law of pre-eclamptics and controls, Br J Obstet Gynaecol, 88, 785, 10.1111/j.1471-0528.1981.tb01304.x

Teft, 2006, A molecular perspective of CTLA-4 function, Annu Rev Immunol, 24, 65, 10.1146/annurev.immunol.24.021605.090535

Tempfer, 2001, An endothelial nitric oxide synthase gene polymorphism is associated with preeclampsia, Hypertens Pregnancy, 20, 107, 10.3109/10641950109152647

Tempfer, 2004, Polymorphisms of thrombophilic and vasoactive genes and severe preeclampsia: a pilot study, J Soc Gynecol Investig, 11, 227, 10.1016/j.jsgi.2003.12.002

Turan, 2010, Glu298Asp polymorphism of the endothelial nitric oxide synthase gene and plasma concentrations of asymmetric dimethylarginine in Turkish pre-eclamptic women without fetal growth retardation, J Obstet Gynaecol Res, 36, 495, 10.1111/j.1447-0756.2010.01172.x

Uma, 2010, Polymorphisms of the angiotensin converting enzyme gene in early-onset and late-onset pre-eclampsia, J Matern Fetal Neonatal Med, 23, 874, 10.3109/14767050903456667

Utermann, 1987, Apolipoprotein E polymorphism in health and disease, Am Heart J, 113, 433, 10.1016/0002-8703(87)90610-7

van Geel, 2000, Angiotensin II type 1 receptor A1166C gene polymorphism is associated with an increased response to angiotensin II in human arteries, Hypertension, 35, 717, 10.1161/01.HYP.35.3.717

van Rijn, 2008, Maternal TLR4 and NOD2 gene variants, pro-inflammatory phenotype and susceptibility to early-onset preeclampsia and HELLP syndrome, PLoS One, 3, e1865, 10.1371/journal.pone.0001865

Veldman, 2002, The Glu298Asp polymorphism of the NOS 3 gene as a determinant of the baseline production of nitric oxide, J Hypertens, 20, 2023, 10.1097/00004872-200210000-00022

von Tempelhoff, 2000, Incidence of the factor V Leiden-mutation, coagulation inhibitor deficiency, and elevated antiphospholipid-antibodies in patients with preeclampsia or HELLP-syndrome. Hemolysis, elevated liver-enzymes, low platelets, Thromb Res, 100, 363, 10.1016/S0049-3848(00)00312-1

Vural, 2010, Tumor necrosis factor alpha, interleukin-6 and interleukin-10 polymorphisms in preeclampsia, J Obstet Gynaecol Res, 36, 64, 10.1111/j.1447-0756.2009.01111.x

Wang, 2000, Endothelial nitric oxide synthase gene sequence variations and vascular disease, Mol Genet Metab, 70, 241, 10.1006/mgme.2000.3033

Wang, 2006, Prolylcarboxypeptidase gene, chronic hypertension, and risk of preeclampsia, Am J Obstet Gynecol, 195, 162, 10.1016/j.ajog.2006.01.079

Wang, 2011, The effect of IL-10 genetic variation and interleukin 10 serum levels on Crohn's disease susceptibility in a New Zealand population, Hum Immunol, 72, 431, 10.1016/j.humimm.2011.02.014

Ward, 1993, A molecular variant of angiotensinogen associated with preeclampsia, Nat Genet, 4, 59, 10.1038/ng0593-59

Watanabe, 2001, Evidence for an association of the R485K polymorphism in the coagulation factor V gene with severe preeclampsia from screening 35 polymorphisms in 27 candidate genes, Thromb Haemost, 86, 1594, 10.1055/s-0037-1616777

Williams, 2004, Methylenetetrahydrofolate reductase 677 C–>T polymorphism and plasma folate in relation to pre-eclampsia risk among Peruvian women, J Matern Fetal Neonatal Med, 15, 337, 10.1080/14767050410001680037

Xie, 2010, Toll-like receptor gene polymorphisms and preeclampsia risk: a case-control study and data synthesis, Hypertens Pregnancy, 29, 390, 10.3109/10641950903242659

Xie, 2011, A meta-analysis of tumor necrosis factor-alpha, interleukin-6, and interleukin-10 in preeclampsia, Cytokine, 56, 550, 10.1016/j.cyto.2011.09.021

Yaghmaei, 2011, Endothelial nitric oxide synthase gene Glu298Asp polymorphism and risk of preeclampsia in South East of Iran, Afr J Biotechnol, 10, 10712, 10.5897/AJB11.895

Yalinkaya, 2006, The relationship between thrombophilic mutations and preeclampsia: a prospective case-control study, Ann Saudi Med, 26, 105, 10.5144/0256-4947.2006.105

Yamada, 2000, The 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene is associated with severe preeclampsia, J Hum Genet, 45, 138, 10.1007/s100380050200

Ye, 1995, The 4G/5G genetic polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene is associated with differences in plasma PAI-1 activity but not with risk of myocardial infarction in the ECTIM study. Etude CasTemoins de I'nfarctus du Mycocarde, Thromb Haemost, 74, 837, 10.1055/s-0038-1649833

Ye, 2006, Seven haemostatic gene polymorphisms in coronary disease: meta-analysis of 66,155 cases and 91,307 controls, Lancet, 367, 651, 10.1016/S0140-6736(06)68263-9

Yilmaz, 2004, Association of pre-eclampsia with hyperhomocysteinaemia and methylenetetrahydrofolate reductase gene C677T polymorphism in a Turkish population, Aust N Z J Obstet Gynaecol, 44, 423, 10.1111/j.1479-828X.2004.00283.x

Yoshida, 2008, Correlation between preeclampsia and prevalence of polymorphism of angiotensinogen, methyleneteterahydrofolate reductase and factor V, prothrombin genes among Japanese women, Acta Med Nagasakiensia, 53, 37

Yoshimura, 2000, Association of the missense Glu298Asp variant of the endothelial nitric oxide synthase gene with severe preeclampsia, J Soc Gynecol Investig, 7, 238

Yoshimura, 2003, Genetic and environmental contributions to severe preeclampsia: lack of association with the endothelial nitric oxide synthase Glu298Asp variant in a developing country, Gynecol Obstet Invest, 56, 10, 10.1159/000072324

Zdoukopoulos, 2011, Polymorphisms of the endothelial nitric oxide synthase (NOS3) gene in preeclampsia: a candidate-gene association study, BMC Pregnancy Childbirth, 11, 89, 10.1186/1471-2393-11-89

Zhang, 2003, A molecular variant of angiotensinogen is associated with idiopathic intrauterine growth restriction, Obstet Gynecol, 101, 237

Zhang, 2006, Functional variants of the lipoprotein lipase gene and the risk of preeclampsia among non-Hispanic Caucasian women, Clin Genet, 69, 33, 10.1111/j.1399-0004.2005.00541.x